

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to gravity (GO:0009629) | 8.23362032 |
| 2 | DNA deamination (GO:0045006) | 5.09282422 |
| 3 | protein deneddylation (GO:0000338) | 4.88752555 |
| 4 | cullin deneddylation (GO:0010388) | 4.86596688 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 4.43095713 |
| 6 | proteasome assembly (GO:0043248) | 4.37158198 |
| 7 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.14398162 |
| 8 | actin-myosin filament sliding (GO:0033275) | 4.12421091 |
| 9 | muscle filament sliding (GO:0030049) | 4.12421091 |
| 10 | skeletal muscle adaptation (GO:0043501) | 4.00197325 |
| 11 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.84644781 |
| 12 | striated muscle atrophy (GO:0014891) | 3.78173285 |
| 13 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.76907373 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.72075849 |
| 15 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.70611108 |
| 16 | adenosine metabolic process (GO:0046085) | 3.69449620 |
| 17 | skeletal muscle tissue regeneration (GO:0043403) | 3.67741250 |
| 18 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.64367190 |
| 19 | cytidine deamination (GO:0009972) | 3.64346539 |
| 20 | cytidine metabolic process (GO:0046087) | 3.64346539 |
| 21 | cytidine catabolic process (GO:0006216) | 3.64346539 |
| 22 | protein K6-linked ubiquitination (GO:0085020) | 3.62733574 |
| 23 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.61824756 |
| 24 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.58296614 |
| 25 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.58296614 |
| 26 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.57964515 |
| 27 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.57964515 |
| 28 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.57964515 |
| 29 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.56346638 |
| 30 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.55887114 |
| 31 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.55887114 |
| 32 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.55107849 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.53801987 |
| 34 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.53801594 |
| 35 | negative regulation of muscle hypertrophy (GO:0014741) | 3.51867364 |
| 36 | protein neddylation (GO:0045116) | 3.50910625 |
| 37 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.46841225 |
| 38 | platelet dense granule organization (GO:0060155) | 3.45026027 |
| 39 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.38762645 |
| 40 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.38762645 |
| 41 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.38077125 |
| 42 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36708230 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.36708230 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.34689969 |
| 45 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.34621764 |
| 46 | ATP synthesis coupled proton transport (GO:0015986) | 3.33398536 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.33398536 |
| 48 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.31903373 |
| 49 | regulation of immunoglobulin secretion (GO:0051023) | 3.30028983 |
| 50 | actin nucleation (GO:0045010) | 3.28643254 |
| 51 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28116811 |
| 52 | actin-mediated cell contraction (GO:0070252) | 3.27791692 |
| 53 | muscle atrophy (GO:0014889) | 3.26801516 |
| 54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.25991795 |
| 55 | sequestering of actin monomers (GO:0042989) | 3.21290954 |
| 56 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.20632592 |
| 57 | response to interferon-beta (GO:0035456) | 3.14737370 |
| 58 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.09494543 |
| 59 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.07775384 |
| 60 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.07396584 |
| 61 | positive regulation of prostaglandin secretion (GO:0032308) | 3.05893166 |
| 62 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.04806740 |
| 63 | regulation of cellular amine metabolic process (GO:0033238) | 3.04585444 |
| 64 | response to muscle activity (GO:0014850) | 3.03155030 |
| 65 | response to testosterone (GO:0033574) | 3.02668111 |
| 66 | retina homeostasis (GO:0001895) | 3.02660961 |
| 67 | cellular response to interleukin-15 (GO:0071350) | 3.02059282 |
| 68 | protein-cofactor linkage (GO:0018065) | 2.99557405 |
| 69 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.99182220 |
| 70 | xenobiotic catabolic process (GO:0042178) | 2.95201638 |
| 71 | positive regulation of defense response to virus by host (GO:0002230) | 2.92764726 |
| 72 | signal peptide processing (GO:0006465) | 2.90310918 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 2.89568205 |
| 74 | positive regulation of ligase activity (GO:0051351) | 2.89498055 |
| 75 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.84905468 |
| 76 | mannosylation (GO:0097502) | 2.79065002 |
| 77 | positive regulation of cell cycle arrest (GO:0071158) | 2.78514611 |
| 78 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.76645820 |
| 79 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.76599401 |
| 80 | protein complex biogenesis (GO:0070271) | 2.74957463 |
| 81 | cellular response to interferon-beta (GO:0035458) | 2.72817305 |
| 82 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.67180878 |
| 83 | regulation of prostaglandin secretion (GO:0032306) | 2.66815157 |
| 84 | rRNA modification (GO:0000154) | 2.66360524 |
| 85 | amino acid salvage (GO:0043102) | 2.65673309 |
| 86 | L-methionine salvage (GO:0071267) | 2.65673309 |
| 87 | L-methionine biosynthetic process (GO:0071265) | 2.65673309 |
| 88 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.64375672 |
| 89 | chaperone-mediated protein transport (GO:0072321) | 2.64375409 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.61842980 |
| 91 | positive regulation of actin filament depolymerization (GO:0030836) | 2.61691458 |
| 92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61041113 |
| 93 | protein polyglutamylation (GO:0018095) | 2.60912507 |
| 94 | protein maturation by protein folding (GO:0022417) | 2.58307801 |
| 95 | branched-chain amino acid catabolic process (GO:0009083) | 2.57423900 |
| 96 | base-excision repair, AP site formation (GO:0006285) | 2.57098231 |
| 97 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.54766042 |
| 98 | mast cell degranulation (GO:0043303) | 2.52628018 |
| 99 | mast cell activation involved in immune response (GO:0002279) | 2.52628018 |
| 100 | NADH dehydrogenase complex assembly (GO:0010257) | 2.50968225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.70543023 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.14332313 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.10407412 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.00024638 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.69903887 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.31404391 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17141533 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.95044982 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.92434464 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81511080 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.69620557 |
| 12 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.69199119 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.68928521 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66451980 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.58300253 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.53815169 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46923533 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39850806 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.32749753 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.20531047 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14644128 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07074669 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04109594 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01695607 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95402014 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94850720 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92039968 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91253950 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84103963 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78274239 |
| 31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72814994 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68201913 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.66326558 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59930912 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.54921266 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54756143 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51709107 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51515618 |
| 39 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50578937 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50217785 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49676514 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46778034 |
| 43 | AR_20517297_ChIP-Seq_VCAP_Human | 1.44354372 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.43313739 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40467133 |
| 46 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.39856614 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36520648 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35075908 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33231707 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32421716 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32068367 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30615786 |
| 53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.30169115 |
| 54 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27072286 |
| 55 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.26411016 |
| 56 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25648113 |
| 57 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.25345405 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23605964 |
| 59 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.20115946 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16736216 |
| 61 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14780225 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13787318 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10953706 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09072889 |
| 65 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09069057 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07427667 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06804199 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06777158 |
| 69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.06743743 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05739583 |
| 71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05650897 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05459145 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.04334069 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02952997 |
| 75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02094635 |
| 76 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.00533740 |
| 77 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99777807 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99307706 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98954328 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96837658 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95463520 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95363689 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95167808 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95167808 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92871671 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90952419 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89866444 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89316407 |
| 89 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88089418 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86519333 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86329571 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 0.84189828 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84066185 |
| 94 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.83962393 |
| 95 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.83405114 |
| 96 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.82839646 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82491360 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82427164 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81984623 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81984623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.64655587 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.41398881 |
| 3 | MP0004147_increased_porphyrin_level | 3.30347389 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.11050647 |
| 5 | MP0000685_abnormal_immune_system | 2.66273066 |
| 6 | MP0003724_increased_susceptibility_to | 2.46931150 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.41557475 |
| 8 | MP0000747_muscle_weakness | 2.33461313 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.29617484 |
| 10 | MP0005387_immune_system_phenotype | 2.24017480 |
| 11 | MP0001790_abnormal_immune_system | 2.24017480 |
| 12 | MP0000749_muscle_degeneration | 2.23908170 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.20958043 |
| 14 | MP0002102_abnormal_ear_morphology | 2.14099432 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.03387564 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.03300920 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.03268577 |
| 18 | MP0003646_muscle_fatigue | 2.01207394 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.00389353 |
| 20 | MP0001800_abnormal_humoral_immune | 2.00354322 |
| 21 | MP0003436_decreased_susceptibility_to | 1.98311501 |
| 22 | MP0009785_altered_susceptibility_to | 1.92275669 |
| 23 | MP0002723_abnormal_immune_serum | 1.91346306 |
| 24 | MP0002736_abnormal_nociception_after | 1.87190265 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.78346777 |
| 26 | MP0001853_heart_inflammation | 1.77498999 |
| 27 | MP0005083_abnormal_biliary_tract | 1.73356326 |
| 28 | MP0002006_tumorigenesis | 1.70762590 |
| 29 | MP0003786_premature_aging | 1.70246262 |
| 30 | MP0008872_abnormal_physiological_respon | 1.67186934 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.65078645 |
| 32 | MP0003195_calcinosis | 1.63391602 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.60725625 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.60458006 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.56348598 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.53624210 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.53583895 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.50458388 |
| 39 | MP0001819_abnormal_immune_cell | 1.49838330 |
| 40 | MP0001873_stomach_inflammation | 1.45296668 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.44790489 |
| 42 | MP0001243_abnormal_dermal_layer | 1.44247259 |
| 43 | MP0001905_abnormal_dopamine_level | 1.41702685 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.41041148 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.38015738 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.36017610 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.35863179 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.35855765 |
| 49 | MP0002106_abnormal_muscle_physiology | 1.31343599 |
| 50 | MP0002269_muscular_atrophy | 1.30670748 |
| 51 | MP0009764_decreased_sensitivity_to | 1.30510761 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.28993658 |
| 53 | MP0005025_abnormal_response_to | 1.23413246 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.23343807 |
| 55 | MP0000751_myopathy | 1.22978277 |
| 56 | MP0002095_abnormal_skin_pigmentation | 1.20630192 |
| 57 | MP0005620_abnormal_muscle_contractility | 1.19091544 |
| 58 | MP0002419_abnormal_innate_immunity | 1.17397534 |
| 59 | MP0002405_respiratory_system_inflammati | 1.15335553 |
| 60 | MP0006054_spinal_hemorrhage | 1.14957226 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.12830022 |
| 62 | MP0003638_abnormal_response/metabolism_ | 1.11883598 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.07264816 |
| 64 | MP0002822_catalepsy | 1.06943772 |
| 65 | MP0004947_skin_inflammation | 1.06736249 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.06359460 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.06274573 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 1.04021980 |
| 69 | MP0002398_abnormal_bone_marrow | 1.03977457 |
| 70 | MP0002722_abnormal_immune_system | 1.02788944 |
| 71 | MP0000716_abnormal_immune_system | 1.02724438 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.02488308 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.02180921 |
| 74 | MP0000759_abnormal_skeletal_muscle | 1.02081271 |
| 75 | MP0002254_reproductive_system_inflammat | 1.01863821 |
| 76 | MP0010155_abnormal_intestine_physiology | 1.01164672 |
| 77 | MP0005165_increased_susceptibility_to | 1.00476548 |
| 78 | MP0003866_abnormal_defecation | 0.99760379 |
| 79 | MP0003718_maternal_effect | 0.97885727 |
| 80 | MP0003045_fibrosis | 0.96394571 |
| 81 | MP0005253_abnormal_eye_physiology | 0.96201179 |
| 82 | MP0002933_joint_inflammation | 0.94111392 |
| 83 | MP0008058_abnormal_DNA_repair | 0.92267960 |
| 84 | MP0008775_abnormal_heart_ventricle | 0.90297787 |
| 85 | MP0008469_abnormal_protein_level | 0.89736238 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.89631921 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.88385412 |
| 88 | MP0005369_muscle_phenotype | 0.87166220 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.86782774 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 0.86347346 |
| 91 | MP0001542_abnormal_bone_strength | 0.84597585 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.84205960 |
| 93 | MP0002429_abnormal_blood_cell | 0.84195189 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.82697137 |
| 95 | MP0004484_altered_response_of | 0.81450161 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.81329055 |
| 97 | MP0004142_abnormal_muscle_tone | 0.80310642 |
| 98 | MP0001529_abnormal_vocalization | 0.77200378 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.74718602 |
| 100 | MP0000427_abnormal_hair_cycle | 0.74018008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 4.40182414 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12627476 |
| 3 | IgG deficiency (HP:0004315) | 4.03599306 |
| 4 | Nemaline bodies (HP:0003798) | 3.87094207 |
| 5 | 3-Methylglutaconic aciduria (HP:0003535) | 3.56475159 |
| 6 | Mitochondrial inheritance (HP:0001427) | 3.55566715 |
| 7 | Absent phalangeal crease (HP:0006109) | 3.48729047 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.41673725 |
| 9 | Increased CSF lactate (HP:0002490) | 3.36755743 |
| 10 | Distal arthrogryposis (HP:0005684) | 3.36474512 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.28922955 |
| 12 | Hepatic necrosis (HP:0002605) | 3.27676403 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.17672062 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.16574795 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 3.14375913 |
| 16 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.09494932 |
| 17 | Abnormality of alanine metabolism (HP:0010916) | 3.09494932 |
| 18 | Hyperalaninemia (HP:0003348) | 3.09494932 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.08476743 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 2.90621467 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.89402518 |
| 22 | Increased serum lactate (HP:0002151) | 2.85731942 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 2.82352497 |
| 24 | Increased IgM level (HP:0003496) | 2.82034177 |
| 25 | Acute encephalopathy (HP:0006846) | 2.79847438 |
| 26 | Exertional dyspnea (HP:0002875) | 2.78520572 |
| 27 | Exercise-induced myalgia (HP:0003738) | 2.77048669 |
| 28 | Round ear (HP:0100830) | 2.70706261 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.68919555 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.67359496 |
| 31 | Progressive macrocephaly (HP:0004481) | 2.66451941 |
| 32 | Stomatitis (HP:0010280) | 2.63377651 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 2.63368136 |
| 34 | Progressive microcephaly (HP:0000253) | 2.62053694 |
| 35 | Lactic acidosis (HP:0003128) | 2.51331458 |
| 36 | Conical tooth (HP:0000698) | 2.51295665 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.50210697 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.48696230 |
| 39 | Abnormal glycosylation (HP:0012345) | 2.48696230 |
| 40 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.48696230 |
| 41 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.48696230 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.48347127 |
| 43 | Myoglobinuria (HP:0002913) | 2.47018275 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.43909809 |
| 45 | Severe combined immunodeficiency (HP:0004430) | 2.39934746 |
| 46 | Periorbital edema (HP:0100539) | 2.34306156 |
| 47 | Exercise intolerance (HP:0003546) | 2.32411222 |
| 48 | Congenital, generalized hypertrichosis (HP:0004540) | 2.32236962 |
| 49 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.28129952 |
| 50 | Methylmalonic aciduria (HP:0012120) | 2.27393080 |
| 51 | Facial edema (HP:0000282) | 2.27014452 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.25633040 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.25312908 |
| 54 | Type 2 muscle fiber atrophy (HP:0003554) | 2.25112659 |
| 55 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23147742 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.21008637 |
| 57 | Cerebral edema (HP:0002181) | 2.16546266 |
| 58 | Optic disc pallor (HP:0000543) | 2.15506684 |
| 59 | Renal cortical cysts (HP:0000803) | 2.13223240 |
| 60 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.10679310 |
| 61 | Abolished electroretinogram (ERG) (HP:0000550) | 2.10521441 |
| 62 | Prostate neoplasm (HP:0100787) | 2.09575849 |
| 63 | Opisthotonus (HP:0002179) | 2.08819619 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.07750049 |
| 65 | Fatigue (HP:0012378) | 2.07538820 |
| 66 | Muscle fiber atrophy (HP:0100295) | 2.06077263 |
| 67 | Hypoproteinemia (HP:0003075) | 2.03482394 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.02417048 |
| 69 | Cholecystitis (HP:0001082) | 2.01950908 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.01950908 |
| 71 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.01434827 |
| 72 | Deformed tarsal bones (HP:0008119) | 2.00084265 |
| 73 | Respiratory failure (HP:0002878) | 1.98088706 |
| 74 | Paralysis (HP:0003470) | 1.95003555 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94699964 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 1.94699964 |
| 77 | Chronic diarrhea (HP:0002028) | 1.94206399 |
| 78 | Abnormality of T cells (HP:0002843) | 1.93539286 |
| 79 | Methylmalonic acidemia (HP:0002912) | 1.92434828 |
| 80 | Neuroendocrine neoplasm (HP:0100634) | 1.92374035 |
| 81 | Hepatosplenomegaly (HP:0001433) | 1.92121603 |
| 82 | Cerebral hypomyelination (HP:0006808) | 1.90425923 |
| 83 | Lethargy (HP:0001254) | 1.88529642 |
| 84 | IgM deficiency (HP:0002850) | 1.85982770 |
| 85 | Brittle hair (HP:0002299) | 1.83143538 |
| 86 | Mask-like facies (HP:0000298) | 1.81661228 |
| 87 | Metabolic acidosis (HP:0001942) | 1.81389585 |
| 88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.80625187 |
| 89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.80625187 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.80330092 |
| 91 | Calcaneovalgus deformity (HP:0001848) | 1.80255808 |
| 92 | Fibular aplasia (HP:0002990) | 1.79831637 |
| 93 | Cerebral hemorrhage (HP:0001342) | 1.78324061 |
| 94 | CNS demyelination (HP:0007305) | 1.76685106 |
| 95 | Poor speech (HP:0002465) | 1.74679311 |
| 96 | Joint swelling (HP:0001386) | 1.73482626 |
| 97 | Constricted visual fields (HP:0001133) | 1.73346399 |
| 98 | Aplastic anemia (HP:0001915) | 1.72785574 |
| 99 | Oligomenorrhea (HP:0000876) | 1.72466308 |
| 100 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.72285243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.29897726 |
| 2 | VRK2 | 3.98933422 |
| 3 | TLK1 | 3.28483910 |
| 4 | TESK1 | 3.18533597 |
| 5 | TXK | 3.02012351 |
| 6 | MAP4K2 | 3.01616835 |
| 7 | LIMK1 | 2.95032338 |
| 8 | TAOK3 | 2.52023898 |
| 9 | PHKG2 | 2.49011274 |
| 10 | PHKG1 | 2.49011274 |
| 11 | BCKDK | 2.42942996 |
| 12 | ZAK | 2.42327920 |
| 13 | VRK1 | 2.13623500 |
| 14 | MST4 | 2.03569556 |
| 15 | KDR | 1.98683444 |
| 16 | TIE1 | 1.92281660 |
| 17 | NUAK1 | 1.91528568 |
| 18 | MAP3K12 | 1.78459598 |
| 19 | NEK1 | 1.63666814 |
| 20 | MAP3K14 | 1.62432877 |
| 21 | MAPKAPK3 | 1.62212383 |
| 22 | DAPK1 | 1.62169874 |
| 23 | OBSCN | 1.43526258 |
| 24 | SRPK1 | 1.42205461 |
| 25 | BUB1 | 1.38061136 |
| 26 | WNK4 | 1.37955798 |
| 27 | PDK2 | 1.24510824 |
| 28 | IKBKB | 1.21591862 |
| 29 | ADRBK2 | 1.19771036 |
| 30 | TBK1 | 1.19110040 |
| 31 | IKBKE | 1.18925180 |
| 32 | CSNK1G3 | 1.11707464 |
| 33 | EIF2AK3 | 1.09008037 |
| 34 | FES | 1.06540030 |
| 35 | EIF2AK2 | 1.05978344 |
| 36 | CCNB1 | 1.03054646 |
| 37 | CSNK1A1L | 1.02860909 |
| 38 | GRK1 | 1.01353161 |
| 39 | MYLK | 0.99301492 |
| 40 | OXSR1 | 0.93897309 |
| 41 | TEC | 0.92849534 |
| 42 | TAF1 | 0.90214505 |
| 43 | MAP2K2 | 0.88624858 |
| 44 | STK39 | 0.86671747 |
| 45 | MAPK13 | 0.84879288 |
| 46 | CSNK1G1 | 0.84044635 |
| 47 | NME2 | 0.83687728 |
| 48 | BMPR2 | 0.82763738 |
| 49 | SCYL2 | 0.82020241 |
| 50 | CAMKK2 | 0.81802499 |
| 51 | CSNK1G2 | 0.80914198 |
| 52 | TRIM28 | 0.80914125 |
| 53 | RPS6KA5 | 0.80352049 |
| 54 | JAK3 | 0.77610842 |
| 55 | CDK8 | 0.76631002 |
| 56 | PTK2B | 0.76509796 |
| 57 | TSSK6 | 0.75055852 |
| 58 | PIK3CG | 0.71729849 |
| 59 | GRK6 | 0.70796612 |
| 60 | MAP2K7 | 0.69545843 |
| 61 | PIM2 | 0.68503961 |
| 62 | AURKA | 0.66912816 |
| 63 | LMTK2 | 0.66556934 |
| 64 | STK16 | 0.57876659 |
| 65 | MAPKAPK5 | 0.57129420 |
| 66 | ERBB3 | 0.56677049 |
| 67 | PLK3 | 0.56525956 |
| 68 | GRK5 | 0.55137295 |
| 69 | ITK | 0.52707289 |
| 70 | SYK | 0.52171165 |
| 71 | SIK3 | 0.49344792 |
| 72 | KIT | 0.46859054 |
| 73 | MUSK | 0.46384703 |
| 74 | DAPK3 | 0.45401899 |
| 75 | DYRK2 | 0.44803622 |
| 76 | MAP4K1 | 0.44561059 |
| 77 | DAPK2 | 0.43266360 |
| 78 | PRKCQ | 0.43098026 |
| 79 | INSRR | 0.42497743 |
| 80 | ILK | 0.42125616 |
| 81 | CSF1R | 0.41075811 |
| 82 | ARAF | 0.41030805 |
| 83 | IGF1R | 0.39482985 |
| 84 | BCR | 0.38730861 |
| 85 | LCK | 0.37492945 |
| 86 | ADRBK1 | 0.36491729 |
| 87 | PBK | 0.35898008 |
| 88 | CSK | 0.35483824 |
| 89 | EIF2AK1 | 0.35393630 |
| 90 | TRPM7 | 0.35232264 |
| 91 | ABL2 | 0.35076712 |
| 92 | LYN | 0.34326886 |
| 93 | CAMK2G | 0.30521424 |
| 94 | CHUK | 0.30460405 |
| 95 | MAPKAPK2 | 0.29582559 |
| 96 | ATR | 0.27725308 |
| 97 | ABL1 | 0.27679983 |
| 98 | GRK7 | 0.24807271 |
| 99 | EPHA2 | 0.23933958 |
| 100 | WNK3 | 0.23438329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.41224210 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80304111 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.75339495 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.61434867 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55203612 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.51734322 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.50650082 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.42553120 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28727085 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.19872010 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00094383 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99010356 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.95251686 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.93862772 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88175461 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88163637 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66258157 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.65093159 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.56074155 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.51822037 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46173541 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44130274 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39362879 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32982451 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27809191 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26608079 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22855908 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15985199 |
| 29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12538636 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10150834 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.05359421 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.01847573 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98044323 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96189609 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96109204 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 0.94605688 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 0.93966330 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93875656 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93777214 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93651840 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92484975 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91791506 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.91396445 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91225350 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90525852 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90200663 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90037509 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89561915 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89407639 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87958565 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 0.87489755 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.87360455 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85014250 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.85011528 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83342131 |
| 56 | DNA replication_Homo sapiens_hsa03030 | 0.83017515 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.82081611 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.81739410 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 0.80850514 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75034339 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74698415 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72970247 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72575944 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 0.71782841 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71453452 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70368903 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67719926 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64650816 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61948697 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.61485916 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59352276 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59216608 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57746535 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56525934 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55134409 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.54474194 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54281148 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.54055357 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52456926 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.51703182 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50999928 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50782813 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50704824 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.50565362 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49327165 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48960772 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47978027 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47663939 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46680736 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44563286 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41857604 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.38333215 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38241496 |
| 94 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35744691 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35598049 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35225185 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34961868 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29845568 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29324550 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26585726 |

